| scholarly article | Q13442814 |
| P50 | author | Sean Tutton | Q87530651 |
| P2093 | author name string | David M King | |
| Meena Bedi | |||
| P2860 | cites work | Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases | Q39366326 |
| Pelvic osteoplasty in osteolytic metastases: technical approach under fluoroscopic guidance and early clinical results | Q39372096 | ||
| Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study | Q39392355 | ||
| Percutaneous osteoplasty as a treatment for painful malignant bone lesions of the pelvis and femur | Q39393631 | ||
| Strontium 89 in the treatment of pain due to diffuse osseous metastases: a university hospital experience. | Q39404506 | ||
| Relative efficacy of 32P and 89Sr in palliation in skeletal metastases | Q39441444 | ||
| Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial | Q39449208 | ||
| A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. | Q39452323 | ||
| Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. | Q39460493 | ||
| Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial | Q39493631 | ||
| A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone | Q39513078 | ||
| Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases | Q39542342 | ||
| The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group | Q39562742 | ||
| Incidence of Fracture Through Metastases in Long Bones | Q43731898 | ||
| Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer | Q48916574 | ||
| Alpha emitter radium-223 and survival in metastatic prostate cancer | Q29617472 | ||
| Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. | Q33224604 | ||
| Bone metastasis: review and critical analysis of random allocation trials of local field treatment | Q33603485 | ||
| The stereotaxic method and radiosurgery of the brain. | Q33975919 | ||
| Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. | Q33991574 | ||
| Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures | Q34512362 | ||
| The management of painful bone metastases with an emphasis on radionuclide therapy | Q34581553 | ||
| Clinical applications of radio-frequency tumor ablation in the thorax | Q34959310 | ||
| Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. | Q35062543 | ||
| Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. | Q35754868 | ||
| Radionuclide Therapy of Bone Metastases | Q36036136 | ||
| Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. | Q36442020 | ||
| Bone metastases: pathophysiology and management policy | Q36630825 | ||
| Palliative radiotherapy trials for bone metastases: a systematic review | Q36784842 | ||
| Radiofrequency ablation of pulmonary malignancies | Q37225519 | ||
| Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma | Q37254116 | ||
| Metastatic bone disease: diagnosis, evaluation, and treatment | Q37504436 | ||
| Stereotactic radiotherapy for pulmonary oligometastases: a systematic review | Q37755949 | ||
| Painful osseous metastases. | Q37904689 | ||
| The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases | Q38001275 | ||
| Bone-targeting radiopharmaceuticals including radium-223. | Q38075735 | ||
| Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease | Q39323300 | ||
| MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience | Q39333946 | ||
| Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. | Q51060767 | ||
| Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. | Q53363634 | ||
| Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. | Q53507042 | ||
| Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial | Q72577078 | ||
| Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects | Q72769997 | ||
| Treatment of colorectal liver metastases by cryotherapy | Q74283009 | ||
| Usefulness of strontium-89 for bone pain palliation in metastatic breast cancer patients | Q74335329 | ||
| Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival | Q79158145 | ||
| Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan | Q80006702 | ||
| Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors | Q80100945 | ||
| Dose-response in stereotactic irradiation of lung tumors | Q81321089 | ||
| Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05) | Q81722935 | ||
| Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases | Q83412925 | ||
| Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected] | Q84037164 | ||
| Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients | Q84265090 | ||
| Stereotactic body radiation therapy for lung metastases | Q84501695 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | minimally-invasive procedures | Q1755504 |
| P304 | page(s) | 719394 | |
| P577 | publication date | 2014-02-11 | |
| P1433 | published in | Minimally Invasive Surgery | Q26841955 |
| P1476 | title | Minimally invasive local treatments for bone and pulmonary metastases | |
| P478 | volume | 2014 |
| Q39103173 | Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods |
| Q38918557 | Computational modeling of radiobiological effects in bone metastases for different radionuclides |
| Q35597400 | Functional genomics screening utilizing mutant mouse embryonic stem cells identifies novel radiation-response genes |
Search more.